Literature DB >> 25017879

Midkine and syndecan‑1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma.

Xiu-Feng Hu1, Jun Yao1, She-Gan Gao1, Yan-Tong Yang1, Xiu-Qing Peng1, Xiao-Shan Feng1.   

Abstract

The present study aimed to determine whether the expression levels of midkine (MK) and syndecan‑1 correlate with the malignant progression and poor prognosis of gastric cardiac adenocarcinoma (GCA). GCA tissue samples (n=72) were obtained from the Department of Pathology of the First Affiliated Hospital of Henan University of Science and Technology (Luoyang, China). The paraffin‑embedded samples had been surgically resected and pathologically diagnosed between 2007 and 2009. Normal gastric cardiac biopsy specimens (n=40) were also collected as the control. The expression levels of MK and syndecan‑1 were assessed by immunohistochemistry using the high‑sensitivity streptavidin‑peroxidase method. Statistical analysis was performed on the data obtained using the SPSS 17.0 statistics package. MK expression was detected in 76.4% of GCA samples and 5% of normal gastric cardiac mucosa specimens. A significant positive correlation was observed between the expression levels of MK and the infiltrative depth of the tumor, the presence of lymph node metastasis and the prognosis of the patients (P<0.05). Syndecan‑1 expression was detected in 38.9% of GCA samples and 100% of normal gastric cardiac mucosa samples. The expression levels of syndecan‑1 were negatively correlated with the grade of differentiation, serosal membrane invasion, lymph node metastasis and the patient's prognosis (P<0.05). Notably, the expression levels of MK and syndecan‑1 were inversely correlated (r=‑0.352, P<0.01) in the GCA tissue samples. These results suggest that high expression levels of MK in GCA tissues may indicate a differentiation stage that is characteristic of malignancy, a late clinical stage and a poor prognosis, whereas increased syndecan‑1 levels may indicate a high degree of differentiation, an early clinical stage and a favorable prognosis. MK and syndecan‑1 may serve as important biomarkers for monitoring the development and progression of GCA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25017879     DOI: 10.3892/mmr.2014.2369

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma.

Authors:  Jing Li; Xiao-Lei Shu; Qing Shao; Qian Luo; Qing-Chun Diao; Xin Zhang; Jiang-Dong Sui; Jing Guo; Dan Tao; Xian Zhou; Ying Wang; Can Wang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 2.  Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.

Authors:  Tünde Szatmári; Rita Ötvös; Anders Hjerpe; Katalin Dobra
Journal:  Dis Markers       Date:  2015-09-01       Impact factor: 3.434

3.  Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.

Authors:  Ivana Miše; Majda Vučić
Journal:  Anal Cell Pathol (Amst)       Date:  2018-07-29       Impact factor: 2.916

4.  Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma.

Authors:  Lijuan Li; Shaohua Song; Xiaoling Fang; Donglin Cao
Journal:  BMC Med Genomics       Date:  2021-01-06       Impact factor: 3.063

5.  Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.

Authors:  Zhaodong Han; Rujun Mo; Shanghua Cai; Yuanfa Feng; Zhenfeng Tang; Jianheng Ye; Ren Liu; Zhiduan Cai; Xuejin Zhu; Yulin Deng; Zhihao Zou; Yongding Wu; Zhouda Cai; Yuxiang Liang; Weide Zhong
Journal:  Front Cell Dev Biol       Date:  2022-04-21

6.  Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer.

Authors:  Xiangrong Cui; Xuan Jing; Qin Yi; Chunlan Long; Jie Tian; Jing Zhu
Journal:  Oncotarget       Date:  2017-11-30

7.  Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.

Authors:  Luo Zhang; Xing Song; Yingjie Shao; Changping Wu; Jingting Jiang
Journal:  Oncotarget       Date:  2018-01-04

8.  Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.

Authors:  Simon Kind; Christina Merenkow; Franziska Büscheck; Katharina Möller; David Dum; Viktoria Chirico; Andreas M Luebke; Doris Höflmayer; Andrea Hinsch; Frank Jacobsen; Cosima Göbel; Sören Weidemann; Christoph Fraune; Christina Möller-Koop; Claudia Hube-Magg; Till S Clauditz; Ronald Simon; Guido Sauter; Waldemar Wilczak; Ahmed Abdulwahab Bawahab; Jakob R Izbicki; Daniel Perez; Andreas Marx
Journal:  Dis Markers       Date:  2019-12-23       Impact factor: 3.434

9.  Understanding the molecular association between hyperkalemia and lung squamous cell carcinomas.

Authors:  Xianping Meng; Hongyan Lu; Xia Jiang; Bin Huang; Song Wu; Guiping Yu; Hongbao Cao
Journal:  BMC Med Genet       Date:  2020-10-22       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.